Gledhill J, Burroughs A, Rolles K, Davidson B, Blizard B, Lloyd G
Department of Psychiatry, Royal Free Hospital, London, UK.
J Psychosom Res. 1999 Apr;46(4):359-68. doi: 10.1016/s0022-3999(98)00123-8.
Psychiatric outcome, quality of life, and alcohol consumption were compared between patients transplanted for alcoholic liver disease and those transplanted for other chronic liver diseases. Instruments used included the Clinical Interview Schedule, the 28-item General Health Questionnaire, the Hospital Anxiety and Depression Scale, and the Nottingham Health Profile. There was no difference between the two groups with regard to median scores or "caseness" on these instruments, except for physical mobility on the Nottingham Health Profile, where the alcoholic group was more likely to experience difficulties (p = 0.03). The majority of those transplanted for alcoholic liver disease remained abstinent, although 7 of the 31 in the alcoholic group (23%) were drinking above recommended safe limits. Psychosocial outcome is similar for individuals transplanted for alcoholic liver disease and those transplanted for other chronic liver diseases. Patients should not be excluded from transplantation on grounds of their drinking history.
对因酒精性肝病接受移植的患者和因其他慢性肝病接受移植的患者的精神科治疗结果、生活质量及饮酒情况进行了比较。所使用的工具包括临床访谈问卷、28项一般健康问卷、医院焦虑抑郁量表以及诺丁汉健康量表。两组在这些工具的中位数得分或“病例状态”方面没有差异,但在诺丁汉健康量表的身体活动能力方面存在差异,酒精性肝病组更有可能出现困难(p = 0.03)。大多数因酒精性肝病接受移植的患者保持戒酒状态,尽管酒精性肝病组的31名患者中有7名(23%)饮酒量超过推荐的安全限度。因酒精性肝病接受移植的个体与因其他慢性肝病接受移植的个体的社会心理治疗结果相似。不应基于饮酒史而将患者排除在移植之外。